Crossmark

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s00345-018-2427-z

Published Online: 2018-08-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marconi, Lorenzo

de Bruijn, Roderick

van Werkhoven, Erik

Beisland, Christian

Fife, Kate

Heidenreich, Axel

Kapoor, Anil

Karam, Jose

Kauffmann, Caroline

Klatte, Tobias

Ljungberg, Boerje

Matin, Surena

Sjoberg, Daniel

Staehler, Michael

Stewart, Grant D.

Tanguay, Simon

Uzzo, Robert

Welsh, Sarah

Wood, Lori

Wood, Chris

Bex, Axel
License Information

Text and Data Mining valid from 2018-08-01
More Information

Article History

Received: 30 May 2018

Accepted: 28 July 2018

First Online: 1 August 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Informed consent was obtained from all individual participants included in the study.